Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1528017
This article is part of the Research Topic Targeted Next-Generation Sequencing for Pathogen and Antimicrobial Resistance (AMR) Identification and Profiling View all 9 articles

Genome drafting of Nosocomial Infection CRE Klebsiella pneumoniae Confirming Resistance to Colistin and Eravacycline, Carrying blaNDM-1, mcr-1, and blaKPC-2, in Neonatology from November to December 2023

Provisionally accepted
Xinlong Zhou Xinlong Zhou 1Kailash Wagh B# Kailash Wagh B# 2*Guizhen Lv Guizhen Lv 3*Devender Sharma Devender Sharma 4*Wei Lei Wei Lei 3
  • 1 Dongguan Maternal and Child Health Hospital, Guangdong, China
  • 2 Dr Ulhas Patil Medical College and Hospital, Jalgaon, Maharashtra, India
  • 3 Dongguan Labway Medical Testing Laboratory Co., Ltd.,, Dongguan, China
  • 4 Himachal School of Dental Medical Sciences, Sundarnagar, India

The final, formatted version of the article will be published soon.

    Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a critical pathogen in healthcare settings, associated with high mortality due to antibiotic resistance. In this study, we report an outbreak of CRKP in a neonatal intensive care unit (NICU) within tertiary hospital. The main goal of this study was to characterize the phenotypic and genomic profiles of the CRKP isolates involved in the outbreak and to gain insights into their resistance mechanisms and transmission dynamics within the NICU. Methods: The study was conducted between November and December 2023 in a 5-bed NICU. Monthly surveillance cultures were performed to monitor colonization and infection with multidrug-resistant organisms. CRKP isolates were obtained from blood and nasal swabs of affected neonates. Identification and antimicrobial susceptibility testing were initially conducted using the VitekĀ®2 system and further confirmed by 16S rRNA sequencing. Whole-genome sequencing (WGS) and antimicrobial resistance (AMR) profiling were performed to identify resistance genes and virulence factors. For genetic analysis, both Illumina shortbread and Nanopore long-read sequencing were used, followed by hybrid assembly for enhanced genome resolution. Plasmid and resistance gene profiles were determined using AMRFinder and PlasmidFinder databases. Results: A total of three CRKP isolates (designated Kp1, Kp2, and Kp3) were identified. Kp1 and Kp2 belonged to sequence type (ST) ST23 and were genetically near-identical, differing by a single allele, while Kp3 was of a distinct sequence type, ST2096, with 245 allelic differences from Kp1 and Kp2. All isolates were resistant to colistin and carried resistance genes, including mcr-1 and blaNDM-1, blaKPC2 confirming carbapenem resistance. Efflux pump genes and aminoglycoside resistance genes were also detected, providing a multifaceted defence against antibiotics. Plasmid analysis identified several incompatibility groups (IncFI, IncHI, IncFIB, IncX), indicating the potential for horizontal gene transfer of resistance determinants. Conclusion: This study highlights the complexity of CRKP outbreaks in neonatal care, with isolates exhibiting resistance mechanisms that complicate treatment.The plasmid profiles suggest these strains are reservoirs for multidrug-resistant genes, emphasizing the strict infection control and ongoing genomic surveillance. For neonatal care, these resistance challenges increase the risk of treatment failures and mortality, underscoring the importance of enhanced infection prevention and novel therapeutic strategies.

    Keywords: carbapenem-resistant Klebsiella pneumoniae, Neonatology, antibiotic resistance, Whole-genome sequencing, nosocomial infections

    Received: 14 Nov 2024; Accepted: 10 Dec 2024.

    Copyright: Ā© 2024 Zhou, Wagh B#, Lv, Sharma and Lei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Kailash Wagh B#, Dr Ulhas Patil Medical College and Hospital, Jalgaon, 425309, Maharashtra, India
    Guizhen Lv, Dongguan Labway Medical Testing Laboratory Co., Ltd.,, Dongguan, China
    Devender Sharma, Himachal School of Dental Medical Sciences, Sundarnagar, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.